- Report
- November 2025
- 50 Pages
Global
From €2387EUR$2,650USD£2,106GBP
- Report
- October 2025
- 188 Pages
Global
From €3193EUR$3,545USD£2,818GBP
€3548EUR$3,939USD£3,131GBP
- Report
- September 2025
- 250 Pages
Global
From €4045EUR$4,490USD£3,569GBP
- Report
- November 2025
- 50 Pages
Global
From €2387EUR$2,650USD£2,106GBP
Pentamidine is an antimicrobial drug used to treat a variety of infectious diseases, including leishmaniasis, African trypanosomiasis, and Pneumocystis jirovecii pneumonia. It is also used to prevent and treat malaria. Pentamidine is administered intravenously or intramuscularly, and is available in both generic and branded formulations. The drug is primarily used in the treatment of HIV-related infections, and is also used to treat other infections such as toxoplasmosis and cryptococcosis.
The pentamidine market is highly competitive, with a number of companies offering generic and branded formulations. Major players in the market include GlaxoSmithKline, Pfizer, Merck, Sanofi, and Novartis. Other companies in the market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more